World's Best Scientists 2026 revealed!

D-Index & Metrics

Genetics

D-Index
74
Citations
23248
World Ranking
1958
National Ranking
8

Ola Myklebost publication distribution in Genetics in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Genetics in 2026. The highlighted bar marks where Ola Myklebost sits on this spectrum.

45–54 publications: 6 scientists 55–64 publications: 10 scientists 65–74 publications: 35 scientists 75–84 publications: 84 scientists 85–94 publications: 102 scientists 95–104 publications: 151 scientists 105–114 publications: 175 scientists 115–124 publications: 203 scientists 125–134 publications: 217 scientists 135–144 publications: 205 scientists 145–154 publications: 193 scientists 155–164 publications: 188 scientists 165–174 publications: 170 scientists 175–184 publications: 178 scientists 185–194 publications: 164 scientists 195–204 publications: 173 scientists 205–214 publications: 159 scientists 215–224 publications: 134 scientists 225–234 publications: 143 scientists 235–244 publications: 105 scientists 245–254 publications: 114 scientists 255–264 publications: 92 scientists 265–274 publications: 88 scientists 275–284 publications: 87 scientists 285–294 publications: 80 scientists 295–304 publications: 62 scientists 305–314 publications: 75 scientists 315–324 publications: 67 scientists 325–334 publications: 60 scientists 335–344 publications: 52 scientists 345–354 publications: 40 scientists 355–364 publications: 48 scientists 365–374 publications: 47 scientists 375–384 publications: 46 scientists 385–394 publications: 31 scientists 395–404 publications: 27 scientists 405–414 publications: 40 scientists 415–424 publications: 30 scientists 425–434 publications: 43 scientists 435–444 publications: 29 scientists 445–454 publications: 14 scientists 455–464 publications: 28 scientists 465–474 publications: 21 scientists 475–484 publications: 21 scientists 485–494 publications: 22 scientists 495–504 publications: 17 scientists 505–514 publications: 12 scientists 515–524 publications: 11 scientists 525–534 publications: 8 scientists 535–544 publications: 8 scientists 545–554 publications: 14 scientists 555–564 publications: 4 scientists 565–574 publications: 11 scientists 575–584 publications: 5 scientists 585–594 publications: 11 scientists 595–604 publications: 12 scientists 605–614 publications: 7 scientists 615–624 publications: 6 scientists 625–634 publications: 10 scientists 635–644 publications: 9 scientists 645–654 publications: 10 scientists 655–664 publications: 6 scientists 665–674 publications: 6 scientists 675–684 publications: 6 scientists 685–694 publications: 4 scientists 695–702 publications: 6 scientists 703+ publications: 100 scientists
45 publications 703+

This scientist: 232 publications — 61st percentile

61% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 703 publications or more.

Ola Myklebost D-index placement in Genetics in 2026

The chart shows the D-index (discipline H-index) distribution of Genetics scientists ranked by Research.com in 2026. The highlighted bar marks where Ola Myklebost sits on this spectrum.

40–41 D-Index: 24 scientists 42–43 D-Index: 52 scientists 44–45 D-Index: 84 scientists 46–47 D-Index: 112 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 141 scientists 52–53 D-Index: 143 scientists 54–55 D-Index: 145 scientists 56–57 D-Index: 179 scientists 58–59 D-Index: 162 scientists 60–61 D-Index: 175 scientists 62–63 D-Index: 191 scientists 64–65 D-Index: 172 scientists 66–67 D-Index: 184 scientists 68–69 D-Index: 164 scientists 70–71 D-Index: 158 scientists 72–73 D-Index: 150 scientists 74–75 D-Index: 136 scientists 76–77 D-Index: 127 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 111 scientists 82–83 D-Index: 110 scientists 84–85 D-Index: 110 scientists 86–87 D-Index: 84 scientists 88–89 D-Index: 102 scientists 90–91 D-Index: 66 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 70 scientists 96–97 D-Index: 54 scientists 98–99 D-Index: 60 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 55 scientists 104–105 D-Index: 45 scientists 106–107 D-Index: 42 scientists 108–109 D-Index: 28 scientists 110–111 D-Index: 39 scientists 112–113 D-Index: 25 scientists 114–115 D-Index: 31 scientists 116–117 D-Index: 29 scientists 118–119 D-Index: 34 scientists 120–121 D-Index: 29 scientists 122–123 D-Index: 29 scientists 124–125 D-Index: 18 scientists 126–127 D-Index: 27 scientists 128–129 D-Index: 22 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 11 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 12 scientists 138–139 D-Index: 21 scientists 140–141 D-Index: 4 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 14 scientists 146–147 D-Index: 6 scientists 148–149 D-Index: 10 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 9 scientists 154–155 D-Index: 8 scientists 156–157 D-Index: 8 scientists 158–159 D-Index: 9 scientists 160+ D-Index: 96 scientists
40 D-Index 160+

This scientist: 74 D-Index — 56th percentile

56% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 160 D-Index or more.

Overview

Ola Myklebost is affiliated with the University of Bergen in Norway and has developed a research profile centered on biochemistry, genetics, molecular biology, and medicine. Their work spans multiple specialties with notable contributions in cancer research, molecular biology, pulmonary and respiratory medicine, oncology, and pathology and forensic medicine.

The scientist's publication record includes a significant focus on cancer-related topics, particularly around diagnostics and molecular mechanisms. Key subjects in their research include:

  • Cancer Genomics and Diagnostics
  • Sarcoma Diagnosis and Treatment
  • RNA modifications and cancer
  • Cancer-related molecular mechanisms research
  • Lymphoma Diagnosis and Treatment
  • Ubiquitin and proteasome pathways
  • Soft tissue tumor case studies

Ola Myklebost has published extensively in prominent venues, with frequent contributions to:

  • Nature Communications
  • Genome Medicine
  • Pathology
  • Leukemia
  • Science

Recent papers by the scientist include:

  • Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden, 2021, Nature Communications
  • Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour, 2021, Pathology
  • Clonal evolution after treatment pressure in multiple myeloma: heterogenous genomic aberrations and transcriptomic convergence, 2022, Leukemia
  • Heritable defects in telomere and mitotic function selectively predispose to sarcomas, 2023, Science
  • Cell Fusion of Mesenchymal Stem/Stromal Cells and Breast Cancer Cells Leads to the Formation of Hybrid Cells Exhibiting Diverse and Individual (Stem Cell) Characteristics, 2020, International Journal of Molecular Sciences

Throughout their career, Ola Myklebost has collaborated with several frequent co-authors, including:

  • Leonardo A. Meza-Zepeda
  • Eivind Hovig
  • Sigve Nakken
  • Daniel Vodák
  • Kjetil Boye

Best Publications

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements

    Leming Shi;Laura H. Reid;Wendell D. Jones;Richard Shippy

  • Surface location and high affinity for calcium of a 500-kd liver membrane protein closely related to the LDL-receptor suggest a physiological role as lipoprotein receptor.

    J. Herz;U. Hamann;S. Rogne;Ola Myklebost

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Small-molecule MDM2 antagonists reveal aberrant p53 signaling in cancer: implications for therapy.

    Christian Tovar;James Rosinski;Zoran Filipovic;Brian Higgins

  • Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone.

    Sam Behjati;Sam Behjati;Patrick S Tarpey;Nadège Presneau;Susanne Scheipl;Susanne Scheipl

  • Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents

    Emilie P. Buddingh;Marieke L. Kuijjer;Ronald A J Duim;Horst Bürger

  • Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes

    Jose M. C. Tubio;Yilong Li;Young Seok Ju;Inigo Martincorena

  • Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies

    Kaja C. G. Berg;Kaja C. G. Berg;Peter W. Eide;Peter W. Eide;Ina A. Eilertsen;Ina A. Eilertsen;Bjarne Johannessen;Bjarne Johannessen

  • Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs

    Heidi M. Namløs;Leonardo A. Meza-Zepeda;Leonardo A. Meza-Zepeda;Tale Barøy;Ingrid H G Østensen

  • Structure of the Supernumerary Ring and Giant Rod Chromosomes in Adipose Tissue Tumors

    Florence Pedeutour;Anne Forus;Jean Michel Coindre;Jeanne Marie Berner

  • Levels of nm23 messenger RNA in metastatic malignant melanomas: inverse correlation to disease progression.

    Vivi Ann Flørenes;Steinar Aamdal;Ola Myklebost;Gunhild M. Maelandsmo

  • MDM2 Gene Amplification and Transcript Levels in Human Sarcomas: Relationship to TP53 Gene Status

    Vivi Ann Flørenes;Gunhild Mari Mælandsmo;Anne Forus;Åshild Andreassen

  • Functional characterisation of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes

    S U Lauvrak;E Munthe;S H Kresse;E W Stratford

  • Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma

    Sam Behjati;Sam Behjati;Patrick S. Tarpey;Kerstin Haase;Hongtao Ye

  • Monogenic and polygenic determinants of sarcoma risk: an international genetic study

    Mandy L. Ballinger;Mandy L. Ballinger;Mandy L. Ballinger;David L. Goode;David L. Goode;Isabelle Ray-Coquard;Paul A. James;Paul A. James

  • Molecular characterization of commonly used cell lines for bone tumor research: a trans-European EuroBoNet effort

    Laura Ottaviano;Karl Ludwig Schaefer;Melanie Gajewski;Wolfgang Huckenbeck

  • Performance comparison of four exome capture systems for deep sequencing

    Chandra Sekhar Reddy Chilamakuri;Susanne Lorenz;Mohammed Amin Madoui;Daniel Vodák;Daniel Vodák

  • Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential

    Princy Francis;Heidi Maria Namløs;Christoph Müller;Patrik Edén

  • High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence.

    Leonardo A. Meza-Zepeda;Leonardo A. Meza-Zepeda;Agate Noer;John Arne Dahl;Francesca Micci

Frequent Co-Authors

Leonardo A. Meza-Zepeda
Leonardo A. Meza-Zepeda Oslo University Hospital
Eivind Hovig
Eivind Hovig University of Oslo
Ragnhild A. Lothe
Ragnhild A. Lothe University of Oslo
Øystein Fodstad
Øystein Fodstad Oslo University Hospital
Florence Pedeutour
Florence Pedeutour Grenoble Alpes University
Rolf Inge Skotheim
Rolf Inge Skotheim Oslo University Hospital
Adrienne M. Flanagan
Adrienne M. Flanagan University College London
Erlend B. Smeland
Erlend B. Smeland Oslo University Hospital
Peter J. Campbell
Peter J. Campbell Wellcome Sanger Institute
David C. Wedge
David C. Wedge University of Manchester

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Genetics in the USA opens doors to a range of educational and career opportunities, many of which can be pursued online. Students often seek specialized certifications, such as medical coding and billing certification, to complement genetics studies and work in healthcare administration.

If you’re looking to accelerate your entry into the workforce, fast track schools offer programs that allow you to complete your degree in less time than traditional pathways. This is ideal for students eager to begin their careers or pursue advanced studies faster.

Many learners require flexibility due to work or family responsibilities. Accredited self-paced online courses provide a convenient option, enabling you to learn and progress at your own speed while maintaining balance with other commitments.

Additionally, budget-conscious students can take advantage of online colleges with open enrollment and no application fee. This removes barriers to higher education, making it easier to start your journey in genetics or a related field.

Best Scientists Citing Ola Myklebost

Trending Scientists